- Name: Qiaoqiao Li
- Title: Chief Physician
- Email: liqq@sysucc.org.cn
- Phone:
Dr. Qiaoqiao Li is an professor of radiation oncology at Sun Yat-sen University Cancer Center. Dr. Li obtained her Bachelor and PhD at Sun Yat-sen University, P. R. China in 2000 and 2009, respectively. After she got the MD, she joined the Department of Radiation Oncology at Sun Yat-sen University Cancer Center as a resident in July 2000. She got the attending,associate professorand professerposition of Radiation Oncology in 2005,2013 and 2022 respectively. From Feb 2013 to August 2014, she was trained as a visiting scientist of Radiation Oncology at MD Anderson Cancer Centre in Houston, Texas, U.S.She worked in Dominica as an oncologist of the Chinese meidical team from 2021-2022 and got lot of experience of English medical communication.
Radiation therapy for thoracic cancer, includinglung cancer and esophageal cancer, soft tissue sarcoma in adults and primary/metastasis bone malignancy.
M.B., 1995.9-2000.7 Sun-Yat-Sen University, Guangzhou, P.R. China
M.S., 2003.9-2006.9 Cancer Center, Sun-Yat-Sen University, Guangzhou, P.R. China,
Ph. D of Radiation Oncology, 2006.9-2009.12 Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, P.R. China.
2.Joe Y Chang, Qiao-Qiao Li, Qing-Yong Xu, Pamela K Allen, Neal Rebueno, Daniel R Gomez, Peter Balter, Ritsuko Komaki, Reza Mehran, Stephen G Swisher, Jack A Roth. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". Int J Radiat Oncol Biol Phys, 2014, 1;88(5):1120-8.
3.Qiaoqiao Li, Sha Zhou, Shiliang Liu, Songran Liu, Hong Yang, Lei Zhao, Mengzhong Liu, Yonghong Hu, Mian Xi. Treatment-Related Lymphopenia Predicts Pathologic Complete Response and Recurrence in Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy. Ann Surg Oncol, 2019; 26(9):2882-2889.
4.Baoqing Chen, Meiling Deng, Chen Yang, Mihnea P Dragomir, Lei Zhao, Kunhao Bai, Mian Xi, Yonghong Hu, Yujia Zhu, Qiaoqiao Li. High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis. Radiother Oncol, 2021, 158:191-199.
5.Baoqing Chen, Chen Yang, Mihnea P Dragomir, Dongmei Chi, Wenyan Chen, David Horst, George A Calin, Qiaoqiao Li. Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Ther Adv Med Oncol, 2022; 15:14:17588359221111703.
6.Wenyan Chen, Chen Yang, Biqi Chen, Mian Xi, Baoqing Chen, Qiaoqiao Li. Management of metastatic bone disease of melanoma.Melanoma Res, 2024;1;34(1):22-30.
7.Yujia Zhu, Jing Wen, Qiaoqiao Li, Baoqing Chen, Lei Zhao, Shiliang Liu, Yadi Yang, Sifen Wang, Yingxin Lv, Jibin Li, Li Zhang, Yonghong Hu, Mengzhong Liu, Mian Xi . Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial. Lancet Oncol, 2023;24(4):371-382.
8.Ruixi Wang, Yihong Ling, Baoqing Chen, Yujia Zhu, Yonghong Hu, Mengzhong Liu, Yadi Yang, Li Zhang, Yingxin Lv, Shiliang Liu, Qiaoqiao Li , Mian Xi. Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial. EClinicalMedicine, 2024;30:75:102806.